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Abstract We identified macrophage migration inhibitory factor 
(MIF) mRNA expression in human cornea, and demonstrated its 
immunohistological localization. Reverse transcription-polymer- 
ase chain reaction analysis revealed that MIF mRNA was 
expressed in both the corneal epithelial and endothelial cells. 
Immunohistochemical study using the polyclonal antibody 
prepared from immunizing a rabbit with human recombinant 
MIF showed that MIF was present in the basal cells of corneal 
epithelium and endothelial cells. The fact that MIF exists in 
those cells of the cornea indicates that MIF may play an 
important role in corneal cell immunity and cellular differentia- 
tion. 
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Reverse transcription-polymerase chain reaction 
been considered to be expressed exclusively in activated T- 
lymphocytes; however, a recent report indicated that macro- 
phages are another major source of MIF [10]. Recently, we 
cloned rat MIF cDNA, reported its physicochemical proper- 
ties [11,12], and succeeded in the crystallization of both hu- 
man and rat MIF [13,14]. Moreover, we presented the tertiary 
structure of rat MIF at 2.2/k resolution [15]. 
During the course of our MIF study, we unexpectedly 
found that MIF mRNA was expressed in the human cornea. 
In the present study, we report for the first time that MIF is 
highly expressed in corneal epithelial and endothelial cells as 
demonstrated by reverse transcription-polymerase chain reac- 
tion (RT-PCR) and immunohistochemical analysis. The novel 
localization of MIF may indicate a new biological aspect of 
MIF. 
2. Materials and methods 
1. Introduction 
Corneal epithelial cells and endothelial cells have different 
embryogenic origins, and distinct functions. Corneal epithelial 
cells are nonkeratinized, stratified squamous cells derived 
from surface ctoderm [1]. The basal epithelial cells proliferate 
throughout life, and the progeny cells migrate from the basal 
layer to the surface [2]. Epithelial cells form a layer protecting 
the surface of the cornea, and perform a barrier function in 
the regulation of corneal hydration. In response to wounding, 
surface defects are healed by proliferation and migration of 
the epithelial cells. On the other hand, corneal endothelial 
cells are derived from neural crest cells [3]. Endothelial cells 
have a limited capacity to proliferate following wounding, and 
endothelial defects are closed by a combination of cell 
enlargement and migration. 
Several studies have suggested that epidermal growth factor 
(EGF), basic fibroblast growth factor (basic FGF), and inter- 
leukin-lc~ (IL-lc0 can regulate specific functions in corneal 
epithelial cells [4-6]. EGF and basic FGF have been shown 
to stimulate proliferation of corneal epithelial cells in culture 
and to increase the rate of healing of epithelial wounds. On 
the other hand, there is limited information available concern- 
ing factors that might regulate human corneal endothelial 
cells. Recently it has been reported that basic FGF stimulates 
corneal endothelial cell growth and wound healing [7]. 
Macrophage migration inhibitory factor (MIF) was the first 
lymphokine reported in the guinea pig [8]. It has the ability to 
prevent he migration of macrophages out of capillary tubes. 
Human MIF cDNA has been cloned, and it was shown that 
MIF consists of 114 amino acid residues [9]. MIF has long 
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2.1. Materials 
The following materials were obtained from commercial sources. 
Nitrocellulose membrane filters from Millipore (Bedford, MA, 
USA); Isogen RNA extraction kit from Nippon Gene (Tokyo, Ja- 
pan); M-MLV reverse transcriptase from Gibco (Grand Island, NY, 
USA); Taq DNA polymerase from Perkin-Elmer (Norwalk, CO, 
USA); horseradish peroxidase-conjugated goatanti-rabbit antibody 
from Pierce (Rockford, IL, USA); 4-chloro-l-naphthol substrate for 
horseradish peroxidase from Promega Corp. (Madison, WI, USA); 
Tween 20 from Kanto (Tokyo, Japan); complete Freund's adjuvant 
(CFA), incomplete Freund's adjuvant (IFA) and 3,3'-diaminobenzi- 
dine tetrahydrochloride from Wako (Osaka, Japan); alkylacrylates 
from Merck (Darmstadt, Germany); poly(L-lysine) from Sigma (St. 
Lous, MO, USA); Vector ABC Kit from Vector Laboratories (Bur- 
lingame, CA, USA); Konica immunostaining HRP-1000 from Konica 
(Tokyo, Japan), and Protein A-Sepharose from Pharmacia (Uppsala, 
Sweden). All other chemicals used were of analytical grade. 
2.2. Preparation of antisera 
Polyclonal anti-human MIF serum was generated by immunizing 
New Zealand White rabbits with purified recombinant human MIF. 
Human recombinant MIF was expressed in E. coli and purified to 
homogeneity aspreviously described [12]. In brief, the rabbits were 
inoculated intradermally with 100 ~tg of MIF emulsified in CFA at 
weeks 1 and 2, and with 50 I.tg of MIF in IFA at week 4. Immune 
serum was collected 1week after the last inoculation. The IgG frac- 
tion was prepared using Protein A-Sepharose according to the man- 
ufacturer's protocol. 
2.3. RT-PCR analysis 
Two normal corneas and lens specimens were obtained from two 
patients with malignant orbital tumors after receiving their written 
informed consent. No apparent inflammation or tumor invasion was 
observed in the ocular tissues examined inthe present study. Quarters 
of the corneal button and lens were used for RT-PCR analysis with- 
out fixation. Total RNAs were extracted from the corneal epithelium, 
endothelium and lens with an Isogen RNA extraction kit. The corneal 
epithelium and endothelium were separated from the corneal stroma 
by fine forceps. The reverse transcription ofthe RNAs was carried out 
by M-MLV reverse transcriptase using oligo(dT) primer and subse- 
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quent amplification using Taq DNA polymerase. PCR was carried out 
for 40 cycles of denaturation at94°C for 1 min, annealing at 53°C for 
2 min and extension at 72°C for 1 min using a thermal cycler (Perkin- 
Elmer, Model 2400). MIF primers used were 5'-CTCTCCGAGCT- 
CACCCAGCAG-3' (58-78) (forward) and 5'°CGCGTTCATGTCG- 
TAATAGTT-3' (292-312) (reverse). ~-Actin primers used were 5'- 
CGTTCTGGCGGCACCACCAT-3' (936-935) (forward) and 5'- 
GCAACTAAGTCATAGTCCGC-Y (1170-1189) (reverse). After 
PCR, the amplified products were analyzed by agarose gel electro- 
phoresis. 
2.4. Western blot analysis 
Half of the remaining corneal button and lens was used for Western 
blot analysis as described [16]. In brief, the samples were dissolved in 
20 jal of Tris-HC1 (50 raM, pH 6.8) containing 2-mercaptoethanol 
(1%), sodium dodecyl sulfate (SDS) (2%), glycerol (20%) and bromo- 
phenol blue (BPB) (0.04%), and heated at 100°C for 5 min. The 
samples were subjected to SDS-polyacrylamide g l electrophoresis 
(SDS-PAGE) as described [17]. The electrophoresed proteins were 
transferred onto a nitrocellulose sheet at 50 mA for 1 h using a 
semi-dry blot transfer apparatus (Bio-Rad). Then the sheet was inten- 
sively washed with phosphate-buffered saline (PBS), and incubated 
with an anti-human MIF polyclonal antibody (1:1000 dilution) for 
1 h at room temperature, and reacted with peroxidase-conjugated 
anti-rabbit IgG serum (1:1000 dilution) for 1 h at room temperature. 
After the reaction, proteins were visualized with a Konica immuno- 
staining HRP-1000 as recommended in the manufacturer's protocol. 
Protein concentration was determined with a Micro BCA protein 
assay reagent kit (Pierce). 
2.5. Immunohistochemistry 
The remaining quarters of the corneal button and lens were fixed 
overnight in paraformaldehyde (4%) in (PBS). Then, 8-pm thick fro- 
zen sections were cut with a Leica 1720 cryostat (Nussloch, Germany) 
and mounted on poly(L-lysine)-coated slides. The tissue samples were 
immersed in 100% methanol containing hydrogen peroxide (0.3%) for 
30 min to quench internal peroxidase reactivities. Subsequently, they 
were stained with an avidin-biotin-peroxidase complex procedure 
using a Vector ABC Kit according to the manufacturer's protocol. 
Non-specific staining was blocked by incubation for 30 min with 
normal goat serum (10%). The sections were further incubated over- 
night at 4°C with the anti-human MIF polyclonal antibody. After 
three washes with PBS, the samples were reacted with biotinated 
goat anti-rabbit IgG and avidin-biotin complex at room temperature 
for 30 min. The reaction was developed in 3,3'-diaminobenzidine tet-
rahydrochloride containing hydrogen peroxide (0.01%), and the tissue 
samples were mounted with alkylacrylates. 






Fig. 1. RT-PCR analysis of MIF mRNA. RT-PCR was carried out 
as described in section 2. The PCR products were electrophoresed 
on 2% agarose gel. Lanes: 1, corneal epithelium; 2, corneal en- 
dothelium; 3, lens; 4, molecular size marker (pBR322 DNAIAluI). 
The RT-PCR product of ~l-actin is shown at the bottom of each 
lane. 
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Fig. 2. Western blotting analysis of the corneal epithelium, endothe- 
lium, and lens for MIF. Each tissue sample was collected, electro- 
phoresed, transferred to a nitrocellulose membrane, and visualized 
by Konica immunostaining HRP-1000. Lanes: 1, recombinant hu- 
man MIF (50 ng); 2, corneal epithelium (40 ktg protein); 3, corneal 
endothelium (50 ~tg protein); 4, lens (20 ~tg protein); 5, prestained 
molecular marker (Biolabs). 
3. Results 
3.1. RT -PCR 
MIF  mRNA expression in the human corneal epithelium, 
endothelium and lens was examined by RT-PCR analysis. At 
the expected molecular size (255 bp) of MIF  RT-PCR prod- 
ucts were observed on the agarose gel on the epithelium and 
endothelium of the cornea and lens (Fig. 1). Even though RT- 
PCR is not necessarily quantitative, the relative MIF  mRNA 
expression appeared to be greatest in the lens, and lesser in the 
epithelium and endothelium as assumed from the fluorescence 
intensities of their PCR products normalized by the intensities 
of ~-actin. 
3.2. Western blot analysis 
To further confirm the presence of M1F, Western blot anal- 
ysis was carried out. The tissue samples from the corneal 
epithelium, endothelium, and lens were electrophoresed on a 
polyacrylamide gel and transferred electrophoretically to a 
nitrocellulose membrane. The transferred protein bands visua- 
lized by the immunostaining kit migrated to the correspond- 
ing molecular weight of MIF, about 12.5 kDa (Fig. 2). Pre- 
immune rabbit IgG did not react with human MIF  in the 
immunoblot analysis (data not shown). This result indicated 
that MIF  was biosynthesized in each of the ocular tissues. 
3.3. Immunohistochemistry 
We carried out immunohistochemical analysis for the spe- 
cific detection of MIF  using an anti-human MIF  antibody. 
Positive MIF  staining was observed on the basal cell layers of 
both corneal epithelium (Fig. 3a) and endothelial cells (Fig. 
3c). In detail, the cytosols of these cells were strongly and 
exclusively stained; however, stromal cells did not react well 
with the antibody. Lens epithelial cells of the equator also 
showed positive staining (Fig. 3d). In the absence of the 
anti-human MIF  primary antibody or with the addition of 
an excess amount of recombinant MIF, this staining proce- 
dure did not result in any specific staining (Fig. 3b). These 
facts revealed that MIF  was present in the cytosols of human 
epithelial and endothelial cells as well as that of lens cells. 
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4. Discussion 
In the present study, we demonstrated for the first time that 
MIF was expressed in human corneal epithelial and endothe- 
lial cells by RT-PCR, and the presence of MIF was further 
confirmed by Western blot and immunohistochemical anal- 
yses. MIF was considered to be largely expressed in T-lym- 
phocytes and macrophages. A major problem for research in 
this area has been the limited availability of human tissue and 
lack of an appropriate animal model. To solve this problem, 
PCR was effectively used to demonstrate he presence of MIF 
in human corneal epithelial and endothelial cells. This proce- 
dure revealed that MIF mRNA was expressed in human cor- 
neal epithelial and endothelial cells. This fact may provide 
novel information on the physiological functions of MIF. 
Recently, the essential roles of growth factors in regulating 
cells have been shown in various tissues. They contribute to 
normal homeostasis and responses to stimuli such as wound- 
ing or infection. As for the physiology of the human eye, the 
endogenous production of growth factors by human corneal 
epithelial and endothelial cells has been reported [6]. It has 
been demonstrated that EGF, and basic EGF can modulate 
corneal epithelial cell proliferation and migration [4,5]. Wis- 
tow et al. recently described MIF mRNA expression i  differ- 
entiating chicken lens cells, and reported that this correlated 
with cell differentiation [18]. Here, we demonstrated the posi- 
tive immunostaining of MIF for differentiating human lens 
cells, in particular around the equatorial epithelium (Fig. 
3d). The immunohistological results obtained on the human 
lens are consistent with their findings. 
On the other hand, MIF in the human cornea has not been 
investigated. The present study demonstrated that MIF 
mRNA was expressed in normal corneal epithelium and en- 
dothelium (Fig. 1). This constant expression of MIF mRNA 
suggests the possibility that the protein plays an important 
role in the maintenance of cellular functions. Moreover, 
MIF may possibly contribute to differentiation of the epithe- 
lial cells, because the basal cells of the corneal epithelium are 
considered to have a similar potential for differentiation, as in 
lens equatorial epithelium. Taken together, these results sug- 
gest that MIF is important in the cytokine network for the 
differentiation of the human cornea. 
MIF, originally identified as a lymphokine concentrating 
macrophages at inflammatory sites, is a potent activator of 
macrophages [19]. Langerhans cells are known to be present 
as unique inflammation-related c lls in cornea. It is often ob- 
served that Langerhans cells, antigen-presenting cells of 
macrophage origin in the cornea, migrate toward the central 
region during inflammation [20]. Considering these facts, MIF 
may play a critical role in enhancement of Langerhans cell 
migration in the case of corneal inflammation. Furthermore, 
MIF may contribute to the formation of the keratic precipi- 
tate in granulomatous uveitis, where macrophages tend to 
adhere to each other and to the corneal endothelium to 
form large precipitates [21]. It is widely accepted that leakage 
of cellular proinflammatory proteins from the injured cornea 
enhances ocular inflammation. 
Although we discovered the presence of MIF in human 
corneal epithelial and endothelial cells, the essential function 
of MIF in ocular regions remains ambiguous. Recently, MIF 
was found to be a glucocorticoid induced modulator of cyto- 
kine production [22], indicating that MIF is a critical compo- 
Fig. 3. Immunohistochemical study of MIF in the human corneal epithelium, endothelium, and lens. Tissue preparation and immunohistochem- 
ical staining were carried out as described in section 2. (a) Corneal epithelium (x 60); (b) control tissue specimen reacted with pre-immune rab- 
bit IgG (x60); (c) endothelium (x60); (d) lens epithelium (x60). En, Ep, and C denote the corneal endothelium, lens epithelium, and lens 
capsule, respectively. 
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nent of the immune system and acts together with glucocorti- 
coids to regulate immunity and inflammation. Considering 
this fact, it is speculated that MIF  may play an important 
role in corneal cell immunity, its inflammatory process, and 
possibly cell proliferation. Further in vivo and in vitro inves- 
tigations are underway to elucidate the pathophysiological 
roles of MIF. 
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